Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin and Vismodegib +/- Decitabine in AML
NCT02073838Phase 2Completed
- Start
- May 2015
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ribavirin in acute myeloid leukemia (AML). Started May 2015; status: completed.
02
Drugs
ribavirin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02073838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073838.